Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.

Rickels MR, Mueller R, Markmann JF, Naji A.

J Clin Endocrinol Metab. 2009 Jan;94(1):181-9. doi: 10.1210/jc.2008-1806. Epub 2008 Oct 28.

2.

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.

Rickels MR, Mueller R, Teff KL, Naji A.

J Clin Endocrinol Metab. 2010 Mar;95(3):1238-46. doi: 10.1210/jc.2009-2289. Epub 2010 Jan 22.

3.

Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients.

Rickels MR, Naji A.

Diabetes Obes Metab. 2010 Aug;12(8):731-3. doi: 10.1111/j.1463-1326.2010.01208.x.

4.

Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.

Kielgast U, Asmar M, Madsbad S, Holst JJ.

J Clin Endocrinol Metab. 2010 May;95(5):2492-6. doi: 10.1210/jc.2009-2440. Epub 2010 Mar 5.

PMID:
20207828
5.
6.

Endocrine secretory reserve and proinsulin processing in recipients of islet of langerhans versus whole pancreas transplants.

Elkhafif NM, Borot S, Morel P, Demuylder-Mischler S, Giovannoni L, Toso C, Bosco D, Berney T.

Diabetes Care. 2013 Nov;36(11):3726-31. doi: 10.2337/dc12-2710. Epub 2013 Sep 16.

7.

Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.

da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM, Rutter GA.

Diabetologia. 2012 Oct;55(10):2667-76. doi: 10.1007/s00125-012-2600-7. Epub 2012 Jun 21.

PMID:
22717537
8.

Effect of glucagon-like peptide-1 (7-37) on beta-cell function after islet transplantation in type 1 diabetes.

Fung M, Thompson D, Shapiro RJ, Warnock GL, Andersen DK, Elahi D, Meneilly GS.

Diabetes Res Clin Pract. 2006 Nov;74(2):189-93. Epub 2006 Apr 18.

PMID:
16621111
9.

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.

Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.

Diabetes. 1996 Nov;45(11):1524-30.

PMID:
8866556
10.
11.

Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.

Byrne MM, Gliem K, Wank U, Arnold R, Katschinski M, Polonsky KS, Göke B.

Diabetes. 1998 Aug;47(8):1259-65.

PMID:
9703326
12.

Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.

Pørksen N, Grøfte B, Nyholm B, Holst JJ, Pincus SM, Veldhuis JD, Schmitz O, Butler PC.

Diabetes. 1998 Jan;47(1):45-9.

PMID:
9421373
13.

Assessment of β-cell mass and α- and β-cell survival and function by arginine stimulation in human autologous islet recipients.

Robertson RP, Bogachus LD, Oseid E, Parazzoli S, Patti ME, Rickels MR, Schuetz C, Dunn T, Pruett T, Balamurugan AN, Sutherland DE, Beilman G, Bellin MD.

Diabetes. 2015 Feb;64(2):565-72. doi: 10.2337/db14-0690. Epub 2014 Sep 3.

14.

Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.

Kumar DP, Asgharpour A, Mirshahi F, Park SH, Liu S, Imai Y, Nadler JL, Grider JR, Murthy KS, Sanyal AJ.

J Biol Chem. 2016 Mar 25;291(13):6626-40. doi: 10.1074/jbc.M115.699504. Epub 2016 Jan 12.

PMID:
26757816
15.

Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Gudipaty L, Rosenfeld NK, Fuller CS, Gallop R, Schutta MH, Rickels MR.

Diabetes Care. 2014 Sep;37(9):2451-8. doi: 10.2337/dc14-0398. Epub 2014 Jun 26.

17.

Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.

Schwasinger-Schmidt T, Robbins DC, Williams SJ, Novikova L, Stehno-Bittel L.

Pharmacol Res. 2013 Oct;76:58-66. doi: 10.1016/j.phrs.2013.07.005. Epub 2013 Jul 26.

18.

Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.

Christiansen E, Tibell A, Vølund A, Rasmussen K, Groth CG, Holst JJ, Pedersen O, Christensen NJ, Madsbad S.

J Clin Endocrinol Metab. 1996 Nov;81(11):3972-9.

PMID:
8923846
19.

Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.

Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG.

J Clin Invest. 1996 Jun 1;97(11):2611-8.

20.

Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).

Clocquet AR, Egan JM, Stoffers DA, Muller DC, Wideman L, Chin GA, Clarke WL, Hanks JB, Habener JF, Elahi D.

Diabetes. 2000 Nov;49(11):1856-64.

PMID:
11078452
Items per page

Supplemental Content

Write to the Help Desk